Key Advertising Pitfalls the MHRA Wants You to Avoid
Why the MHRA Is Watching Your Adverts
The Medicines and Healthcare products Regulatory Agency (MHRA) has a clear message for pharmaceutical advertisers: compliance is not optional. Yet every year, the same avoidable errors appear in promotional materials, costing companies time, money, and reputation.

At the upcoming mhraadvertisingseminar.co.uk event, experts will dissect the most frequent pitfalls. This article previews what they will highlight and how you can sidestep each one before your next campaign goes live.
Pitfall One: Missing or Vague Risk Information
One of the most common mistakes is burying side effects or omitting them entirely. The MHRA requires that risk information be prominent, legible, and balanced against efficacy claims.
Seminar speakers will show real examples where small print or fast voiceovers led to enforcement action. To avoid this, ensure every advert includes a clear, unmissable safety statement.
"If a patient cannot easily see the risks, the advert is non-compliant by design."
Pitfall Two: Off-Label Promotion
Promoting a medicine for an unlicensed indication is a serious breach. This often happens subtly, through case studies or patient testimonials that hint at uses beyond the approved label.
The seminar will walk through how to audit your claims against the Summary of Product Characteristics. Train your copywriters to flag any language that strays from authorised indications.
Pitfall Three: Inadequate Record-Keeping
Even a perfectly worded advert fails if you cannot prove it was approved and monitored. The MHRA expects detailed records of sign-off, distribution, and any complaints received.
Use a central log for every promotional item. The table below summarises what the seminar recommends you track:
| Record Type | Required Detail | Retention Period |
|---|---|---|
| Approval sign-off | Name, date, role | 5 years |
| Distribution list | Channels, dates | 5 years |
| Complaints log | Issue, action taken | 5 years |
Pitfall Four: Ignoring Digital and Social Media Rules
Many advertisers assume that short posts or paid ads are exempt. They are not. The MHRA applies the same standards to tweets, LinkedIn posts, and banner ads as to print materials.
To stay compliant, avoid hashtags that make unapproved claims, and never use influencers without a clear, approved script. The seminar will offer a digital checklist you can adapt immediately.
How to Sidestep These Pitfalls
Preparation beats correction. Start by building a compliance review into every stage of campaign development, not as a final checkbox.
- Train all staff on the MHRA Blue Guide and relevant case law.
- Use a pre-launch checklist that mirrors the seminar's top ten risks.
- Schedule quarterly audits of live adverts and social posts.
- Appoint a single compliance lead with authority to halt publication.
By attending the mhraadvertisingseminar.co.uk, you will gain practical tools to avoid these pitfalls. Do not wait for a warning letter. Act now to protect your brand and your patients.
